Aehr/$AEHR

AEHR plunges after Q1 FY26 results showed revenue fell to $11.0m and a GAAP net loss of $2.1m, down from $13.1m revenue and a $0.7m profit in the year-ago period.
7 hours agoLightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aehr

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Ticker

$AEHR

Sector

Semiconductors
Primary listing

Employees

136

Aehr Metrics

BasicAdvanced
$949M
-
-$0.13
2.48
-

What the Analysts think about Aehr

Analyst ratings (Buy, Hold, Sell) for Aehr stock.

Bulls say / Bears say

Aehr’s fiscal Q3 FY2025 net revenue surged to $18.3 million from $7.6 million a year earlier, representing a 140% YoY increase driven by strong demand for its semiconductor test equipment.
On a non-GAAP basis, Aehr’s Q3 FY2025 net income reached $2.0 million (EPS $0.07), compared to a non-GAAP loss of $0.9 million in the prior-year quarter, showing significant profitability growth.
Aehr closed Q4 FY2025 with a backlog of $15.2 million (effective backlog $16.3 million), more than double the level of the previous year, providing solid revenue visibility into fiscal 2026.
Aehr’s fiscal Q4 FY2025 net revenue fell 15% year-over-year to $14.1 million from $16.6 million, missing consensus expectations and highlighting weaker order timing.
The company posted a GAAP net loss of $2.9 million (EPS –$0.10) in Q4 FY2025, down from a GAAP net income of $23.9 million for the same quarter last year, indicating a significant earnings decline.
Cash, cash equivalents, and restricted cash decreased by $4.9 million to $26.5 million at the end of Q4 FY2025 from $31.4 million in Q3, reducing the company’s liquidity position.
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Aehr Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aehr Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AEHR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs